Quest Diagnostics Incorporated Stock Fundamentals
| DGX Stock | USD 128.64 0.11 0.09% |
Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.
At this time, Quest Diagnostics' EBITDA is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 18.8 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 280.4 M in 2024. Quest | Select Account or Indicator |
Quest Diagnostics Incorporated Company Operating Margin Analysis
Quest Diagnostics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Quest Diagnostics Operating Margin | 0.13 % |
Most of Quest Diagnostics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Quest Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Quest Diagnostics Incorporated has an Operating Margin of 0.1294%. This is 100.37% lower than that of the Health Care Providers & Services sector and 100.2% lower than that of the Health Care industry. The operating margin for all United States stocks is 102.35% lower than that of the firm.
Quest Diagnostics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quest Diagnostics's current stock value. Our valuation model uses many indicators to compare Quest Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quest Diagnostics competition to find correlations between indicators driving Quest Diagnostics's intrinsic value. More Info.Quest Diagnostics Incorporated is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Quest Diagnostics Incorporated is roughly 2.35 . At this time, Quest Diagnostics' Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Quest Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Quest Diagnostics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quest Diagnostics' earnings, one of the primary drivers of an investment's value.Quest Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.Quest Diagnostics is currently under evaluation in operating margin category among related companies.
Quest Diagnostics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Quest Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0621 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 19.16 B | ||||
| Shares Outstanding | 111.06 M | ||||
| Shares Owned By Insiders | 0.43 % | ||||
| Shares Owned By Institutions | 91.73 % | ||||
| Number Of Shares Shorted | 2.55 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 2.26 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 9.25 B | ||||
| Gross Profit | 3.47 B | ||||
| EBITDA | 1.26 B | ||||
| Net Income | 850 M | ||||
| Cash And Equivalents | 315 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 5.37 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 56.82 X | ||||
| Cash Flow From Operations | 1.27 B | ||||
| Short Ratio | 2.81 X | ||||
| Earnings Per Share | 7.49 X | ||||
| Price To Earnings To Growth | 1.52 X | ||||
| Target Price | 142.29 | ||||
| Number Of Employees | 40 K | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 14.29 B | ||||
| Total Asset | 14.02 B | ||||
| Retained Earnings | 8.82 B | ||||
| Working Capital | 557 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.89 % | ||||
| Net Asset | 14.02 B | ||||
| Last Dividend Paid | 2.84 |
About Quest Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -1.4 B | -1.3 B | |
| Total Revenue | 9.3 B | 6.9 B | |
| Cost Of Revenue | 6.2 B | 4.2 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.22 | 0.28 | |
| Research And Ddevelopement To Revenue | 0.00 | 0.00 | |
| Capex To Revenue | (0.04) | (0.05) | |
| Revenue Per Share | 82.61 | 86.74 | |
| Ebit Per Revenue | 0.15 | 0.10 |
Check out Quest Diagnostics Piotroski F Score and Quest Diagnostics Altman Z Score analysis. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.868 | Dividend Share 2.84 | Earnings Share 7.49 | Revenue Per Share 82.607 | Quarterly Revenue Growth (0.02) |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.